# ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Study · id `cardio:ct-nct07687056` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07687056](<https://clinicaltrials.gov/study/NCT07687056>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07687056

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT07687056. Randomized; single masking; primary purpose treatment. Start 2026-08-11 (actual); primary completion 2030-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT07687056, source copy `cardio:ctgov-nct07687056-2026-10-21`, retrieved 2026-10-26)
- Started: 2026-08-11 (actual) (ClinicalTrials.gov record NCT07687056, source copy `cardio:ctgov-nct07687056-2026-10-21`, retrieved 2026-10-26)
- Primary completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT07687056, source copy `cardio:ctgov-nct07687056-2026-10-21`, retrieved 2026-10-26)
- Completion: 2031-03-31 (anticipated) (ClinicalTrials.gov record NCT07687056, source copy `cardio:ctgov-nct07687056-2026-10-21`, retrieved 2026-10-26)
- Countries: Australia; Canada (ClinicalTrials.gov record NCT07687056, source copy `cardio:ctgov-nct07687056-2026-10-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07687056-2026-10-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
- Acronym: ACT-REACT
- Condition: Stroke, Acute Ischemic
- Condition: Endovascular Thrombectomy
- Condition: Acute Ischemic Stroke AIS
- Intervention (Biological): Tenecteplase or Alteplase- depending upon availability at each treating centre
- Intervention (Other): Control
- Lead sponsor: University of Calgary
- Lead sponsor class: OTHER
- Collaborator: The George Institute for Global Health, Australia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Calgary (`cardio:org-university-of-calgary`)
- Registry lists this organization as a collaborator: The George Institute for Global Health (`core:george-institute`)

## Provenance

Content hash: b172ce90a020c5c3616f7035b7c5b8c49dfafd88dc969a811ae1053c738fe968
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
